Apellis Announces Top-Line Results from Phase 3 DERBY and OAKS Studies in Geographic Atrophy (GA) and Plans to Submit NDA to FDA in the First Half of 2022
OAKS met the primary endpoint for both monthly and every-other-month treatment with pegcetacoplan, demonstrating a…
CTF Life Launches MyWealth Beyond Savings Insurance Plan
6 Ways to Avoid Hidden Fees When Spending Overseas
China Chunlai Announces 2026 Interim Results
FREELANDER 8 Production-Intent Show Model Makes Global Debut: First Complete Look at the Legend Reborn
How to Sell a Business Without a Broker: New Course Helps Owners Keep More of Their Money